Minnesota | No. 41-1580506 | |
(State or Other Jurisdiction of | (IRS Employer | |
Incorporation or Organization) | Identification No.) |
2
3
4
Page | ||||
6 | ||||
CONSOLIDATED FINANCIAL STATEMENTS |
||||
7 | ||||
8 | ||||
9 | ||||
10 | ||||
11 | ||||
30 |
5
6
2006 | 2005 | |||||||
(Restated) | ||||||||
ASSETS |
||||||||
CURRENT ASSETS |
||||||||
Cash |
$ | 987,465 | $ | 1,471,505 | ||||
Trade and other accounts receivable, less allowances of $283,100 and $200,700 |
12,404,856 | 8,839,046 | ||||||
Prepaid expenses and other |
701,889 | 509,273 | ||||||
Deferred tax assets |
217,476 | 337,800 | ||||||
Total current assets |
14,311,686 | 11,157,624 | ||||||
PROPERTY AND EQUIPMENT, net |
767,675 | 347,820 | ||||||
OTHER ASSETS |
||||||||
Goodwill |
14,509,469 | 12,919,689 | ||||||
Software technology, less accumulated amortization of $370,200 and $0 |
1,658,575 | 1,762,000 | ||||||
Customer contracts, less accumulated amortization of $1,815,000 and $1,626,100 |
| 188,889 | ||||||
Trademark, less accumulated amortization of $246,300 and $147,000 |
246,809 | 346,057 | ||||||
Other intangible assets, less accumulated amortization of $166,500 and $88, 000 |
362,528 | 441,086 | ||||||
Deferred tax assets |
437,010 | 374,500 | ||||||
Other |
24,597 | 47,105 | ||||||
$ | 32,318,349 | $ | 27,584,770 | |||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
CURRENT
LIABILITIES |
||||||||
Trade accounts payable |
$ | 1,811,939 | $ | 687,125 | ||||
Accrued salaries, wages, and payroll taxes |
3,249,424 | 2,693,927 | ||||||
Accrued acquisition earnout |
1,475,000 | | ||||||
Other accrued liabilities |
120,044 | 763,115 | ||||||
Accrued self funded insurance |
201,053 | 250,000 | ||||||
Deferred revenue |
1,663,121 | 1,868,446 | ||||||
Total current liabilities |
8,520,581 | 6,262,613 | ||||||
LONG-TERM OBLIGATIONS |
| | ||||||
COMMITMENTS AND CONTINGENCIES |
| | ||||||
WARRANT OBLIGATION |
| 2,210,889 | ||||||
PREFERRED STOCK, $0.01 par value; 10,000,000 shares authorized, 0 and 1,000 shares
issued and outstanding at December 31, 2006 and 2005 |
| 8,623,546 | ||||||
STOCKHOLDERS EQUITY |
||||||||
Common stock, $0.01 par value; 50,000,000 shares authorized; 19,220,217 and
13,787,349 shares issued and outstanding at December 31, 2006 and 2005 |
192,202 | 137,874 | ||||||
Additional paid-in capital |
27,565,901 | 15,625,425 | ||||||
Accumulated comprehensive income from foreign currency translation |
(35,186 | ) | 1,245 | |||||
Accumulated deficit |
(3,925,149 | ) | (5,276,822 | ) | ||||
23,797,768 | 10,487,722 | |||||||
$ | 32,318,349 | $ | 27,584,770 | |||||
7
2006 | 2005 | 2004 | ||||||||||
(Restated) | ||||||||||||
REVENUE |
$ | 63,578,540 | $ | 54,942,205 | $ | 52,454,668 | ||||||
COSTS OF REVENUE |
45,947,956 | 41,125,031 | 38,995,451 | |||||||||
GROSS PROFIT |
17,630,584 | 13,817,174 | 13,459,217 | |||||||||
OPERATING EXPENSES |
||||||||||||
Salaries |
8,544,885 | 5,769,082 | 5,600,203 | |||||||||
Other selling, general and administrative |
5,040,709 | 3,712,429 | 3,440,134 | |||||||||
Amortization of acquired intangible assets |
368,618 | 821,611 | 878,333 | |||||||||
Total operating expenses |
13,954,212 | 10,303,122 | 9,918,670 | |||||||||
OPERATING INCOME |
3,676,372 | 3,514,052 | 3,540,547 | |||||||||
OTHER INCOME (EXPENSE) |
||||||||||||
Interest expense |
(7,512 | ) | (25,965 | ) | (465,571 | ) | ||||||
Interest costs early debt repayment |
| | (474,669 | ) | ||||||||
Change in fair value of warrants |
841,215 | (634,435 | ) | | ||||||||
Other, net |
9,646 | 10,585 | 1,642 | |||||||||
EARNINGS BEFORE INCOME TAXES |
4,519,721 | 2,864,237 | 2,601,949 | |||||||||
INCOME TAX EXPENSE |
1,495,184 | 1,518,946 | 927,929 | |||||||||
NET EARNINGS |
3,024,537 | 1,345,291 | 1,674,020 | |||||||||
Deemed dividend to preferred shareholders |
1,576,454 | | | |||||||||
Dividend to preferred shareholders |
96,410 | 140,890 | 86,400 | |||||||||
NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS |
$ | 1,351,673 | $ | 1,204,401 | $ | 1,587,620 | ||||||
NET EARNINGS PER COMMON SHARE: |
||||||||||||
Basic |
$ | 0.07 | $ | 0.09 | $ | 0.13 | ||||||
Diluted |
0.03 | 0.08 | 0.10 | |||||||||
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: |
||||||||||||
Basic |
18,023,298 | 12,780,724 | 12,503,345 | |||||||||
Diluted |
18,772,675 | 16,929,636 | 16,151,017 |
8
Additional | Accumulated | Total | ||||||||||||||||||||||||||
Common Stock | Paid-in | Comprehensive | Accumulated | Stockholders | Comprehensive | |||||||||||||||||||||||
Shares | Amount | Capital | Income | Deficit | Equity | Income | ||||||||||||||||||||||
BALANCE AT JANUARY 1, 2004 |
12,357,334 | 123,573 | 17,671,536 | 5,707 | (8,068,843 | ) | 9,731,973 | |||||||||||||||||||||
Issuance of common stock through stock
purchase plan |
80,454 | 805 | 70,736 | | | 71,541 | ||||||||||||||||||||||
Issuance of common stock for options |
66,100 | 661 | 34,586 | | | 35,247 | ||||||||||||||||||||||
Issuance of common stock for board of
directors compensation |
40,000 | 400 | 60,200 | | | 60,600 | ||||||||||||||||||||||
Issuance of common stock for warrants |
38,282 | 383 | (383 | ) | | | | |||||||||||||||||||||
Dividend to preferred shareholders |
| | | | (86,400 | ) | (86,400 | ) | ||||||||||||||||||||
Net earnings |
| | | | 1,674,020 | 1,674,020 | $ | 1,674,020 | ||||||||||||||||||||
Foreign currency translation |
| | | (3,248 | ) | | (3,248 | ) | (3,248 | ) | ||||||||||||||||||
Comprehensive Income |
$ | 1,670,772 | ||||||||||||||||||||||||||
BALANCE AT DECEMBER 31, 2004 |
12,582,170 | 125,822 | 17,836,675 | 2,459 | (6,481,223 | ) | 11,483,733 | |||||||||||||||||||||
Issuance of common stock through stock
purchase plan |
89,227 | 892 | 162.116 | | | 163,008 | ||||||||||||||||||||||
Issuance of common stock for options |
98,681 | 987 | 14,566 | | | 15,553 | ||||||||||||||||||||||
Issuance of common stock for acquisition |
847,281 | 8,473 | 1,991,527 | | | 2,000,000 | ||||||||||||||||||||||
Issuance of common stock for warrants |
169,990 | 1,700 | (1,700 | ) | | | | |||||||||||||||||||||
Net repurchase of Series A preferred
stock and warrants |
| | (3,539,466 | ) | | | (3,539,466 | ) | ||||||||||||||||||||
Payment of Series B preferred stock
financing costs |
| | (813,021 | ) | | | (813,021 | ) | ||||||||||||||||||||
Reallocation of deferred financing costs |
| | (25,272 | ) | | | (25,272 | ) | ||||||||||||||||||||
Dividend to preferred shareholders |
| | | | (140,890 | ) | (140,890 | ) | ||||||||||||||||||||
Net earnings |
| | | | 1,345,291 | 1,345,291 | $ | 1,345,291 | ||||||||||||||||||||
Foreign currency translation |
| | | (1,214 | ) | | (1,214 | ) | (1,214 | ) | ||||||||||||||||||
Comprehensive Income |
$ | 1,344,077 | ||||||||||||||||||||||||||
BALANCE AT DECEMBER 31, 2005 |
13,787,349 | $ | 137,874 | $ | 15,625,425 | $ | 1,245 | $ | (5,276,822 | ) | $ | 10,487,722 | ||||||||||||||||
Issuance of common stock through stock
purchase plan |
90,572 | 905 | 170,384 | | | 171,289 | ||||||||||||||||||||||
Redemption of common stock for option
exercises |
(31,554 | ) | (315 | ) | (67,526 | ) | (67,841 | ) | ||||||||||||||||||||
Issuance of common stock for options |
253,850 | 2,538 | 75,392 | | | 77,930 | ||||||||||||||||||||||
Payment of Series B preferred stock
financing costs |
(161,725 | ) | (161,725 | ) | ||||||||||||||||||||||||
Issuance of common stock for Series B
preferred stock |
5,100,000 | 51,000 | 10,149,000 | | | 10,200,000 | ||||||||||||||||||||||
Reclassification of warrant liability |
1,369,674 | 1,369,674 | ||||||||||||||||||||||||||
Issuance of common stock for board of
directors compensation |
20,000 | 200 | 31,800 | | | 32,000 | ||||||||||||||||||||||
Stock option compensation |
| | 373,477 | | | 373,477 | ||||||||||||||||||||||
Deemed dividend to preferred
shareholders |
| | | | (1,576,454 | ) | (1,576,454 | ) | ||||||||||||||||||||
Dividend to preferred shareholders |
| | | | (96,410 | ) | (96,410 | ) | ||||||||||||||||||||
Net earnings |
| | | | 3,024,537 | 3,024,537 | $ | 3,024,537 | ||||||||||||||||||||
Foreign currency translation |
| | | (36,431 | ) | | (36,431 | ) | (36,431 | ) | ||||||||||||||||||
Comprehensive Income |
$ | 2,988,106 | ||||||||||||||||||||||||||
BALANCE AT DECEMBER 31, 2006 (Restated) |
19,220,217 | $ | 192,202 | $ | 27,565,901 | $ | (35,186 | ) | $ | (3,925,149 | ) | $ | 23,797,768 | |||||||||||||||
9
2006 | 2005 | 2004 | ||||||||||
(Restated) | ||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||||||
Net earnings |
$ | 3,024,537 | $ | 1,345,291 | $ | 1,674,020 | ||||||
Adjustment to reconcile net earnings
to net cash provided by operating activities: |
||||||||||||
Common stock issued for Board of Directors compensation |
32,000 | | 60,600 | |||||||||
Stock-based compensation |
373,477 | | | |||||||||
Depreciation |
538,511 | 88,663 | 93,030 | |||||||||
Amortization |
366,694 | 817,210 | 1,034,654 | |||||||||
Interest on escrow account |
| | (2,611 | ) | ||||||||
Warrant valuation adjustment |
(841,215 | ) | 634,435 | | ||||||||
Deferred taxes |
57,814 | 1,169,200 | 655,101 | |||||||||
Loss on disposal of assets |
| 1,897 | | |||||||||
Interest early debt repayment |
| | 345,754 | |||||||||
Change in assets and liabilities, net of assets acquired: |
||||||||||||
Trade and other accounts receivable |
(3,565,810 | ) | (554,637 | ) | (2,929,206 | ) | ||||||
Prepaid expenses and other |
(192,616 | ) | (295,319 | ) | (26,607 | ) | ||||||
Other assets |
22,508 | 39,910 | (22,557 | ) | ||||||||
Trade accounts payable |
1,088,382 | (222,537 | ) | 267,178 | ||||||||
Accrued liabilities and other |
1,338,479 | 127,031 | 1,204,508 | |||||||||
Deferred revenue |
(205,325 | ) | (175,294 | ) | 550,036 | |||||||
Net cash provided by operating activities |
2,037,436 | 2,975,850 | 2,903,900 | |||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||||||
Purchases of property and equipment |
(854,940 | ) | (232,485 | ) | (66,121 | ) | ||||||
Business acquisitions, net of cash acquired |
(1,589,780 | ) | (4,344,476 | ) | (296,927 | ) | ||||||
Net cash payment made for acquisition |
| (7,085 | ) | | ||||||||
Net cash used in investing activities |
(2,444,720 | ) | (4,584,046 | ) | (363,048 | ) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||||||
Borrowings under note payable |
| 13,899,950 | 18,257,358 | |||||||||
Repayments of note payable |
| (15,512,709 | ) | (19,419,599 | ) | |||||||
Proceeds from cash escrow account |
| | 474,609 | |||||||||
Net proceeds from issuance of preferred stock and warrants |
| 9,386,979 | | |||||||||
Repurchase of equity securities |
| (5,114,382 | ) | | ||||||||
Repayments of long term obligations |
| | (2,000,000 | ) | ||||||||
Costs from the issuance of preferred stock |
(161,725 | ) | | | ||||||||
Proceeds from the issuance of common stock |
171,288 | 163,008 | 71,541 | |||||||||
Proceeds from the exercise of stock options |
10,091 | 15,553 | 35,247 | |||||||||
Payment of Series B preferred stock dividend |
(96,410 | ) | | | ||||||||
Net cash provided by (used in) financing activities |
(76,756 | ) | 2,838,399 | (2,580,844 | ) | |||||||
NET INCREASE (DECREASE) IN CASH |
(484,040 | ) | 1,230,203 | (39,992 | ) | |||||||
CASH AT BEGINNING OF YEAR |
1,471,505 | 241,302 | 281,294 | |||||||||
CASH AT END OF YEAR |
$ | 987,465 | $ | 1,471,505 | $ | 241,302 | ||||||
SUPPLEMENTAL CASH FLOW DISCLOSURES |
||||||||||||
Supplemental cash flow information: |
||||||||||||
Cash paid for interest |
$ | 1,681 | $ | 30,366 | $ | 438,111 | ||||||
Cash paid for taxes |
1,502,987 | 672,147 | 160,827 | |||||||||
Noncash investing and financing activities affecting cash flows: |
||||||||||||
Deemed dividend to preferred shareholders |
(1,576,454 | ) | | | ||||||||
Dividend to preferred shareholders |
| (140,890 | ) | (86,400 | ) | |||||||
Common stock issued in business acquisition |
| 2,000,000 | | |||||||||
Value of warrants issued to placement agents |
| $ | 114,191 | | ||||||||
Redemption of common stock |
(67,841 | ) | | |
10
11
available for general release. Amortization is determined on a product by product basis using the greater of a ratio of current product revenues to projected current and future product revenues or an amount calculated using the straight-line method over the estimated economic life of the product, which is generally three to five years. | ||
Capitalized software development costs are stated at the lower of amortized cost or net realizable value. Recoverability of these capitalized costs is determined by comparing the forecasted future revenues from the related products, based on managements best estimates using appropriate assumptions and projections at the time, to the carrying amount of the capitalized software development costs. If the carrying value is determined not to be recoverable from future revenues, an impairment loss is recognized equal to the amount by which the carrying amount exceeds the future revenues. | ||
During 2006, we capitalized $267,000 of software development costs related to enhancements we made to our eHealth platform, a system we acquired through our acquisition of HealthCalc. Capitalized software development costs are captured within Software Technology. These software development costs will be amortized over the remaining economic life of the eHealth platform, or five years. We expect to recover our capitalized software development costs due to the growth of our Health Management segment. | ||
Goodwill - Goodwill represents the excess of the purchase price and related costs over the fair value of net assets of businesses acquired. The carrying value of goodwill is tested for impairment on an annual basis or when factors indicating impairment are present. Projected discounted cash flows are used in assessing these assets. We elected to complete the annual impairment test of goodwill on December 31 each year and determined that our goodwill relates to two reporting units for purposes of impairment testing. The Company determined that there was no impairment of goodwill at December 31, 2006, 2005, and 2004. | ||
Intangible Assets - Our intangible assets include customer contracts, trademarks and tradenames, software and other intangible assets, all of which are amortized on a straight-line basis. Customer contracts represent the fair value assigned to acquired customer contracts, which are amortized over the remaining life of the contracts, approximately 13-23 months. Trademarks and tradenames represent the value assigned to an acquired trademarks and tradenames, and are amortized over a period of five years. Software represents the value assigned to an acquired web-based software program and is amortized over a period of five years. Other intangible assets include the value assigned to acquired customer lists, which is amortized over a period of six years, as well as deferred financing costs, which are amortized over the term of the related credit agreement. Amortization expense for intangible assets totaled $738,803, $817,210, and $955,422 for the twelve months ended December 31, 2006, 2005, and 2004. | ||
Expected future amortization of intangible assets is as follows: |
Years ending December 31 | ||||
2007 |
$ | 580,171 | ||
2008 |
570,769 | |||
2009 |
504,785 | |||
2010 |
504,785 | |||
Thereafter |
107,402 |
Revenue Recognition Revenue is recognized at the time the service is provided to the customer. We determine our allowance for discounts by considering historical discount history and current payment practices of our customers. For annual contracts, monthly amounts are recognized ratably over the term of the contract. Certain services provided to the customer may vary on a periodic basis and are invoiced to the customer in arrears. The revenues relating to theses services are estimated in the month that the service is |
12
performed. Accounts receivable related to estimated revenues were $1,644,211 and $1,283,979 at December 31, 2006 and 2005. | ||
We also provide services to companies located in Canada. Revenue recognized from our Canadian customers totaled approximately $259,300, $277,600 and $253,200 for the periods ended December 31, 2006, 2005 and 2004. Although we invoice these customers in their local currency, we do not believe there is a risk of material loss due to foreign currency translation. | ||
Amounts received from customers in advance of providing contracted services are treated as deferred revenue and recognized when the services are provided. Accounts receivable relating to deferred revenue were $1,663,121 and $1,868,446 at December 31, 2006 and 2005. | ||
We have contracts with third-parties to provide ancillary services in connection with their fitness and wellness management services and programs. Under such arrangements, the third-parties invoice and receive payments from us based on transactions with the ultimate customer. We do not recognize revenues related to such transactions as the ultimate customer assumes the risk and rewards of the contract and the amounts billed to the customer are either at cost or with a fixed markup. | ||
Advertising The Company expenses advertising costs as they are incurred. Advertising expense for the periods ended December 31, 2006, 2005 and 2004 was $159,646, $119,364 and $118,074. | ||
Comprehensive Income Comprehensive income is net earnings plus certain other items that are recorded directly to stockholders equity. Our comprehensive income represents net earnings adjusted for foreign currency translation adjustments. Comprehensive income is disclosed in the consolidated statement of stockholders equity. | ||
Net Earnings Per Common Share Basic net earnings per common share is computed by dividing net earnings applicable to common shareholders by the number of basic weighted average common shares outstanding. Diluted net earnings per share is computed by dividing net earnings applicable to common shareholders, plus dividends to preferred shareholders (net earnings), less the non-cash benefit related to a change in fair value of warrants by the number of diluted weighted average common shares outstanding, and common share equivalents relating to stock options, stock warrants and stock warrants, if dilutive. Refer to Exhibit 11.0 attached hereto for a detail computation of earnings per share. | ||
Common stock options and warrants to purchase 2,393,681, 517,163 and 400,100 shares of common stock with weighted average exercise prices of $2.51, $2.78 and $2.54 were excluded from the 2006, 2005 and 2004 diluted computation because their exercise price exceeded the average trading price of our common stock during each of the periods. | ||
Stock-Based Compensation We maintain a stock option plan for the benefit of certain eligible employees and directors of the Company. Commencing January 1, 2006, we adopted Statement of Financial Accounting Standard No. 123R, Share Based Payment (SFAS 123R), using the modified prospective method of adoption, which requires all share-based payments, including grants of stock options, to be recognized in the income statement as an operating expense, based on their fair values over the requisite service period. The compensation cost we record for these awards is based on their fair value on the date of grant. The Company continues to use the Black Scholes option-pricing model as its method for valuing stock options. The key assumptions for this valuation method include the expected term of the option, stock price volatility, risk-free interest rate and dividend yield. Many of these assumptions are judgmental and highly sensitive in the determination of compensation expense. Further information on our share-based payments can be found in Note 9 in the Notes to the Consolidated Financial Statements under Item 8. |
13
Fair Values of Financial Instruments Due to their short-term nature, the carrying value of our current financial assets and liabilities approximates their fair values. The fair value of long-term obligations, if recalculated based on current interest rates, would not significantly differ from the recorded amounts. | ||
Valuation of Derivative Instruments In accordance with the interpretive guidance in EITF Issue No. 05-4, The Effect of a Liquidated Damages Clause on a Freestanding Financial Instrument Subject to EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Companys Own Stock, we valued warrants we issued in November 2005 in our financing transaction as a derivative liability. We were required to make certain periodic assumptions and estimates to value the derivative liability. Factors affecting the amount of this liability include changes in our stock price, the computed volatility of our stock price and other assumptions. The change in value is reflected in our statements of operations as non-cash income or expense, and the changes in the carrying value of derivatives can have a material impact on our financial statements. | ||
Income Taxes The Company records income taxes in accordance with the liability method of accounting. Deferred income taxes are provided for temporary differences between the financial reporting and tax basis of assets and liabilities and federal operating loss carryforwards. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of the enactment. We do not record a tax liability or benefit in connection with the change in fair value of certain of our warrants. Income taxes are calculated based on managements estimate of the Companys effective tax rate, which takes into consideration a federal tax rate of 34% and an effective state tax rate of 6%. | ||
Use of Estimates Preparing consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | ||
2. | FINANCING | |
On November 14, 2005 (the Effective Date), in a Private Investment in Public Equity transaction (the PIPE Transaction), we issued an aggregate of 1,000 shares of Series B Convertible Preferred Stock (the Series B Stock), together with warrants to purchase 1,530,000 shares of common stock at $2.40 per share, to a limited number of accredited investors for aggregate gross proceeds of $10.2 million. After selling commissions and expenses, we received net proceeds of approximately $9.4 million. The Series B Stock automatically converted into 5,100,000 shares of our common stock on March 10, 2006, the date the Securities and Exchange Commission (the SEC) first declared effective a registration statement covering these shares. We used the proceeds from this PIPE Transaction to redeem our Series A Convertible Preferred Stock and to fund the acquisition of HealthCalc.Net, Inc. | ||
In accordance with the terms of the PIPE Transaction, we were required to file with the SEC, within sixty (60) days from the Effective Date, a registration statement covering the common shares issued and issuable in the PIPE Transaction. We were also required to cause the registration statement to be declared effective on or before the expiration of one hundred twenty (120) days from the Effective Date. We would have been subject to liquidated damages of one percent (1%) per month of the aggregate gross proceeds ($10,200,000), if we failed to meet these date requirements. On March 10, 2006, the SEC declared effective our registration statement and, as a result, we did not pay any liquidated damages for failure to meet the filing and effectiveness date requirements. We could nevertheless be subject to the foregoing liquidated damages if we fail (subject to certain permitted circumstances) to maintain the effectiveness of |
14
the registration statement. On June 15, 2006, we entered into an agreement with the accredited investors to amend the Registration Rights Agreement to cap the amount of liquidated damages we could pay at 9% of the aggregate purchase price paid by each accredited investor. | ||
The warrants, which were issued together with the Series B Stock, have a term of five years, and give the investors the option to require us to repurchase the warrants for a purchase price, payable in cash within five (5) business days after such request, equal to the Black Scholes value of any unexercised warrant shares, only if, while the warrants are outstanding, any of the following change in control transactions occur: (i) we effect any merger or consolidation, (ii) we effect any sale of all or substantially all of our assets, (iii) any tender offer or exchange offer is completed whereby holders of our common stock are permitted to tender or exchange their shares for other securities, cash or property, or (iv) we effect any reclassification of our common stock whereby it is effectively converted into or exchanged for other securities, cash or property. On June 15, 2006, we entered into an agreement with the accredited investors to amend the Warrant Agreement to give us the ability to repurchase the warrants, in the case of a change in control transaction, using shares of stock, securities or assets, including cash. | ||
Under EITF 00-19 Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Companys Own Stock (EITF 00-19), the fair value of the warrants issued under the PIPE Transaction have been reported as a liability due to the requirement to net-cash settle the transaction. There are two reasons for this treatment: (i) there are liquidated damages, payable in cash, of 1% of the gross proceeds per month ($102,000) should we fail to maintain effectiveness of the registration statement in accordance with the PIPE Transaction; and (ii) our investors may put their warrants back to us for cash if we initiate a change in control that meets the definition previously discussed. As a result of the amendments we structured with the accredited investors on June 15, 2006, we were allowed to account for the warrants as equity. As a result of this accounting change, we made a final valuation of our warrant liability on June 15, 2006, which resulted in non-cash income of $406,694 for our second quarter in 2006, and the remaining warrant liability of $1,369,674 was reclassified to additional paid in capital. We are no longer required to revalue these warrants on a prospective basis. | ||
3. | REPURCHASE OF EQUITY SECURITIES | |
On November 15, 2005, using part of the proceeds from our PIPE Transaction, we redeemed all of the outstanding shares of our Series A Convertible Preferred Stock sold to Bayview Capital Partners LP (Bayview), which were convertible into 2,222,210 shares of common stock, and warrants to purchase 1,213,032 shares of common stock if exercised for cash, or 916,458 shares of common stock if exercised on a cash-less basis. The total cash we used to make this repurchase was approximately $5.1 million. At December 31, 2005, Bayview held warrants to purchase an additional 62,431 shares of common stock at exercise prices ranging from $2.24 to $2.70 per share, which were obtained in connection with anti-dilution rights. We did not repurchase these shares as they were out-of-the-money. |
15
4. | BUSINESS ACQUISITION | |
On December 23, 2005, using substantially all of the remaining proceeds from our PIPE Transaction, we acquired all of the capital stock of HealthCalc. Net, Inc, a leading provider of web-based fitness, health management and wellness programs. We purchased HealthCalc because we believe their proven technology platform will play a very important role in the overall growth strategy related to the corporate health management area of our business. We paid $3.9 million in cash and issued $2 million in common stock, representing 847,281 shares, to HealthCalcs shareholders. | ||
We accounted for this acquisition using the purchase method of accounting. The fair market value of the assets acquired resulted in the following purchase price allocation: |
Cash price paid |
$ | 3,934,108 | ||
Common stock issued |
2,000,000 | |||
Accrued acquisition earnout |
1,475,000 | |||
Acquisition costs |
632,334 | |||
Cash acquired |
(107,187 | ) | ||
Liabilities assumed |
159,277 | |||
Total purchase price |
$ | 8,093,532 | ||
Purchase Price Allocation | ||||
Accounts receivable |
$ | 136,978 | ||
Property and equipment |
55,587 | |||
Software |
1,762,000 | |||
Customer contracts |
85,000 | |||
Trademark/Tradenames |
136,000 | |||
Other intangibles (customer lists) |
431,000 | |||
Excess of cost over assets acquired (goodwill) |
5,486,967 | |||
$ | 8,093,532 | |||
16
Years Ended December 31 | ||||||||
2005 | 2004 | |||||||
Net revenues |
$ | 56,574,309 | $ | 54,084,358 | ||||
Net earnings |
1,687,863 | 1,345,796 | ||||||
Net earnings to common shareholders |
1,546,973 | 1,259,396 | ||||||
Net earnings per common share: |
||||||||
Basic |
$ | 0.11 | $ | 0.09 | ||||
Diluted |
$ | 0.10 | $ | 0.08 | ||||
Weighted average common shares outstanding
|
||||||||
Basic |
13,607,113 | 13,350,626 | ||||||
Diluted |
17,756,025 | 16,998,298 |
The unaudited pro forma condensed consolidated results of operations are not necessarily indicative of results that would have occurred had the acquisition occurred as of January 1, 2004, nor are they necessarily indicative of the results that may occur in the future. | ||
5. | PROPERTY AND EQUIPMENT | |
Property and equipment consists of the following at December 31: |
Useful Life | 2006 | 2005 | ||||||||||
Leasehold improvements |
Term of lease | $ | 11,757 | $ | 11,757 | |||||||
Office equipment |
3-7 years | 1,496,302 | 1,243,844 | |||||||||
Software |
3 years | 235,371 | 218,295 | |||||||||
Health care equipment |
1-5 years | 772,231 | 453,583 | |||||||||
2,515,661 | 1,927,479 | |||||||||||
Less accumulated depreciation and amortization |
1,747,986 | 1,579,659 | ||||||||||
$ | 767,675 | $ | 347,820 | |||||||||
6. | LONG-TERM OBLIGATIONS | |
Our primary source of liquidity and working capital is provided by a $7,500,000 Credit Agreement with Wells Fargo Bank, N.A. (the Wells Loan). At our option, the Wells Loan bears interest at prime, or the one-month LIBOR plus a margin of 2.25% to 2.75% based upon our Senior Leverage Ratio (effective rate of 8.25% and 7.25% at December 31, 2006 and 2005). The availability of the Wells Loan decreases $250,000 on the last day of each calendar quarter, beginning September 30, 2003, and matures on June 30, 2008, as amended. Working capital advances from the Wells Loan are based upon a percentage of our eligible accounts receivable, less any amounts previously drawn. The facility provided maximum borrowing capacity of $4,000,000 and $5,000,000 at December 31, 2006 and 2005, which was available for drawing on such respective dates. All borrowings are collateralized by substantially all of our assets. At December 31, 2006 and 2005, we were in compliance with all of our financial covenants. | ||
7. | COMMITMENTS AND CONTINGENCIES | |
Leases We lease office space and equipment under various operating leases. In addition to base rental payments, these leases require us to pay a proportionate share of real estate taxes, special assessments, and |
17
maintenance costs. The lease for our corporate headquarters, as well as the office lease for HealthCalc, has escalating lease payments through 2007 and 2010. Costs incurred under operating leases are recorded as rent expense and totaled approximately $404,000, $302,000, and $271,000 for the years ended December 31, 2006, 2005, and 2004. | ||
Minimum rent payments due under operating leases are as follows: |
Years ending December 31: | ||||
2007 |
$ | 363,000 | ||
2008 |
177,000 | |||
2009 |
162,000 | |||
2010 |
35,000 | |||
Thereafter |
|
Legal Proceedings We are involved in various claims and lawsuits incident to the operation of our business. We believe that the outcome of such claims will not have a material adverse effect on our financial condition, results of operation, or cash flows. | ||
Liquidated Damages In accordance with the terms of the PIPE Transaction, we were required to file with the SEC, within sixty (60) days from the Effective Date, a registration statement covering the common shares issued and issuable in the PIPE Transaction. We were also required to cause the registration statement to be declared effective on or before the expiration of one hundred twenty (120) days from the Effective Date. We would have been subject to liquidated damages of one percent (1%) per month of the aggregate gross proceeds ($10,200,000), if we failed to meet these date requirements. On March 10, 2006, the SEC declared effective our registration statement and, as a result, we did not pay any liquidated damages for failure to meet the filing and effectiveness date requirements. We could nevertheless be subject to the foregoing liquidated damages if we fail (subject to certain permitted circumstances) to maintain the effectiveness of the registration statement. On June 15, 2006, we entered into an agreement with the accredited investors to amend the Registration Rights Agreement to cap the amount of liquidated damages we could pay at 9% of the aggregate purchase price paid by each accredited investor. | ||
8. | BENEFIT PLAN | |
We maintain a 401(k) plan whereby employees are eligible to participate in the plan providing they have attained the age of 18 and have completed one month of service. The plan was amended in December 2002 to allow participants to contribute up to 20% of their earnings effective April 1, 2003. Previously, participants were able to contribute up to 15% of their earnings. We may make certain matching contributions, which were approximately $297,000, $261,000, and $277,000 for the years ended December 31, 2006, 2005, and 2004. | ||
9. | EQUITY | |
Stock Options We maintain a stock option plan for the benefit of certain eligible employees and our directors. We have authorized 4,000,000 shares for grant under our 2005 Stock Option Plan, and a total of 1,313,275 shares of common stock are reserved for additional grants of options at December 31, 2006. Generally, the options outstanding are granted at prices equal to the market value of our stock on the date of grant, generally vest over four years and expire over a period of six or ten years from the date of grant. | ||
Commencing January 1, 2006, we adopted Statement of Financial Accounting Standard No. 123R, Share Based Payment (SFAS 123R), which requires all share-based payments, including grants of stock |
18
options, to be recognized in the income statement as an operating expense, based on their fair values over the requisite service period. Prior to 2006, the compensation cost we recorded for option awards was based on their grant date fair value as calculated for the proforma disclosures required by Statement 123. | ||
We recorded $373,477 of stock option compensation expense for the twelve months ended December 31, 2006. We also recorded a deferred tax benefit of $149,392 for the twelve months ended December 31, 2006 in connection with recording this non-cash expense. This deferred tax benefit will be adjusted based upon the actual tax benefit realized from the exercise of the underlying stock options. The compensation expense reduced diluted earnings per share by approximately $0.01 for the twelve months ended December 31, 2006. | ||
In 2005 and 2004, we utilized the intrinsic value method of accounting for our stock- based employee compensation plans. All options granted had an exercise price equal to the market value of the underlying common stock on the date of grant and accordingly, no compensation cost is reflected in net earnings for the years ended December 31, 2005 and 2004. The following table illustrates the effect on net earnings and earnings per share if we had applied the fair value method: |
2005 | 2004 | |||||||
Net earnings applicable to common shareholders basic |
$ | 1,204,401 | $ | 1,587,620 | ||||
Add: Dividends to preferred shareholders |
140,890 | 86,400 | ||||||
Net earnings diluted |
1,345,291 | 1,674,020 | ||||||
Less: Compensation expense determined under the fair
value method, net of tax |
(187,898 | ) | (171,500 | ) | ||||
Proforma net earnings, basic |
$ | 1,016,503 | $ | 1,416,120 | ||||
Proforma net earnings, diluted |
$ | 1,157,393 | $ | 1,502,520 | ||||
Net earnings per common share: |
||||||||
Basic-as reported |
$ | 0.09 | $ | 0.13 | ||||
Basic-proforma |
$ | 0.08 | $ | 0.11 | ||||
Diluted-as reported |
$ | 0.08 | $ | 0.10 | ||||
Diluted-proforma |
$ | 0.07 | $ | 0.09 | ||||
As of December 31, 2006, approximately $637,000 of total unrecognized compensation costs related to non-vested awards is expected to be recognized over a weighted average period of approximately 2.60 years. | ||
Prior to adopting SFAS 123R, we accounted for stock-based compensation under Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees. We have applied the modified prospective method in adopting SFAS 123R. Accordingly, periods prior to adoption have not been restated. |
19
Options Outstanding | Options Exercisable | |||||||||||||||||||||||
Weighted Average | Weighted | Weighted | ||||||||||||||||||||||
Remaining | Average | Average | ||||||||||||||||||||||
Range of | Number | Contractual Life | Exercise | Number | Exercise | |||||||||||||||||||
Exercise Prices | Outstanding | In Years | Price | Exercisable | Price | |||||||||||||||||||
$ | 0.30 - $0.39 | 155,400 | 2.12 | $ | 0.39 | 114,675 | $ | 0.39 | ||||||||||||||||
0.47 - 0.69 | 596,650 | 1.45 | 0.56 | 596,650 | 0.56 | |||||||||||||||||||
0.95 - 1.25 | 259,000 | 3.70 | 1.16 | 199,250 | 1.17 | |||||||||||||||||||
1.26 - 2.27 | 458,600 | 3.89 | 1.85 | 341,800 | 1.81 | |||||||||||||||||||
2.28 - 3.00 | 781,250 | 3.60 | 2.74 | 353,625 | 2.81 | |||||||||||||||||||
2,250,900 | 3.00 | $ | 1.64 | 1,606,000 | $ | 1.39 | ||||||||||||||||||
Fiscal Year Ending | ||||||||||||
December 31, | ||||||||||||
2006 | 2005 | 2004 | ||||||||||
Risk-free interest rate |
4.48 | % | 2.79 | % | 3.30 | % | ||||||
Expected volatility |
68.9 | % | 72.4 | % | 88.0 | % | ||||||
Expected life (in years) |
3.96 | 3.04 | 4.00 | |||||||||
Dividend yield |
| | |
Weighted | ||||||||
Number of | Average | |||||||
Shares | Exercise Price | |||||||
Outstanding at January 1, 2004 |
1,710,900 | $ | 0.88 | |||||
Granted |
320,100 | 1.87 | ||||||
Exercised |
(66,100 | ) | 0.53 | |||||
Forfeited |
(43,350 | ) | 0.54 | |||||
Outstanding at December 31, 2004 |
1,921,550 | 1.06 | ||||||
Granted |
357,500 | 2.58 | ||||||
Exercised |
(109,625 | ) | 0.39 | |||||
Forfeited |
(12,000 | ) | 1.94 | |||||
Outstanding at December 31, 2005 |
2,157,425 | 1.34 | ||||||
Granted |
515,500 | 2.43 | ||||||
Exercised |
(253,850 | ) | 0.31 | |||||
Forfeited |
(168,175 | ) | 2.33 | |||||
Outstanding at December 31, 2006 |
2,250,900 | $ | 1.64 | |||||
20
Weighted | ||||||||
Number of | Average | |||||||
Shares | Exercise Price | |||||||
Options exercisable at December 31: |
||||||||
2006 |
1,606,000 | $ | 1.39 | |||||
2005 |
1,520,900 | $ | 1.18 | |||||
2004 |
1,249,450 | $ | 1.05 |
Exercise | ||||||||
Number of | Price | |||||||
Shares | Per Share | |||||||
Outstanding at January 1, 2004 |
1,460,320 | $ | 0.30 0.50 | |||||
Exercised |
(38,282 | ) | 0.30 | |||||
Forfeited |
(6,718 | ) | 0.30 | |||||
Outstanding at December 31, 2004 |
1,415,320 | 0.30 0.50 | ||||||
Granted |
1,697,143 | 0.50 2.70 | ||||||
Exercised |
(1,086,448 | ) | 0.30 0.50 | |||||
Forfeited |
(331,584 | ) | 0.30 0.50 | |||||
Outstanding at December 31, 2005 |
1,694,431 | 2.00 2.70 | ||||||
Granted |
| | ||||||
Exercised |
| | ||||||
Forfeited |
| | ||||||
Outstanding at December 31, 2006 |
1,694,431 | 2.00 2.70 | ||||||
21
Exercise | ||||||||
Number of | Price | |||||||
Shares | Per Share | |||||||
Warrants exercisable at December 31: |
||||||||
2006 |
1,694,431 | $ | 2.00 2.70 | |||||
2005 |
1,694,431 | 2.00 2.70 | ||||||
2004 |
1,415,320 | 0.30 - 0.50 |
10. | INCOME TAXES | |
Income tax expense consists of the following: |
2006 | 2005 | 2004 | ||||||||||
Current |
$ | 1,435,000 | $ | 412,346 | $ | 272,828 | ||||||
Deferred |
60,184 | 1,106,600 | 655,101 | |||||||||
$ | 1,495,184 | $ | 1,518,946 | $ | 927,929 | |||||||
2006 | 2005 | 2004 | ||||||||||
Tax expense computed at statutory rates |
$ | 1,567,910 | $ | 973,800 | $ | 884,700 | ||||||
State tax benefit, net of federal effect |
181,745 | 205,800 | 154,600 | |||||||||
Nontaxable warrant expense (income) |
(286,913 | ) | 215,700 | | ||||||||
Adjustment to income tax provision accruals |
| 110,700 | (199,700 | ) | ||||||||
Other |
32,442 | 12,946 | 88,329 | |||||||||
$ | 1,495,184 | $ | 1,518,946 | $ | 927,929 | |||||||
2006 | 2005 | |||||||
Current: |
||||||||
Allowances |
$ | 69,500 | $ | 8,200 | ||||
Accrued employee benefits |
84,000 | 185,300 | ||||||
State tax loss carryforwards |
64,000 | 144,300 | ||||||
Net current asset |
$ | 217,500 | $ | 337,800 | ||||
Noncurrent: |
||||||||
Depreciation and amortization |
295,200 | $ | 374,500 | |||||
Accrued employee benefits |
141,800 | | ||||||
$ | 437,000 | $ | 374,500 | |||||
22
11. | ACCOUNTING PRONOUNCEMENTS | |
In June 2006, the FASB ratified the consensus reached by the Emerging Issues Task Force on Issue No. 06-3, How Sales Taxes Collected From Customers and Remitted to Governmental Authorities Should Be Presented in the Income Statement (EITF 06-3). EITF 06-3 requires a company to disclose its accounting policy (i.e. gross vs. net basis) relating to the presentation of taxes within the scope of EITF 06-3. Furthermore, for taxes reported on a gross basis, an enterprise should disclose the amounts of those taxes in interim and annual financial statements for each period for which an income statement is presented. The guidance is effective for all periods beginning after December 15, 2006. We do not believe the adoption of EITF 06-3 will have a material effect on our financial position and results of operation. | ||
In July 2006, the FASB issued FASB Interpretation No. 48 (FIN 48), Accounting for Uncertainty in Income Taxes an interpretation of FASB Statement 109. FIN 48 prescribes a comprehensive model for recognizing, measuring, presenting and disclosing in the financial statements, tax positions taken or expected to be taken on a tax return, including the decision whether to file or not to file in a particular jurisdiction. FIN 48 is effective for fiscal years beginning after December 15, 2006. If there are changes in net assets as a result of application of FIN 48, these changes will be accounted for as an adjustment to retained earnings. We do not believe the adoption of FIN 48 will have a material effect on our financial position and results of operation. | ||
In September 2006, the FASB issued SFAS 157, Fair Value Measurements. SFAS 157 does not address what to measure at fair value; instead, it addresses how to measure fair value. SFAS 157 applies (with limited exceptions) to existing standards that require assets or liabilities to be measured at fair value. SFAS 157 establishes a fair value hierarchy, giving the highest priority to quoted prices in active markets and the lowest priority to unobservable data and requires new disclosures for assets and liabilities measured at fair value based on their level in the hierarchy. SFAS 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007. We do not believe the adoption of SFAS 157 will have a material effect on our financial position and results of operation. | ||
In September 2006, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 108 (SAB 108), which became effective on January 1, 2007. SAB 108 provides guidance on the consideration of the effects of prior period misstatements in quantifying current year misstatements for the purpose of a materiality assessment. SAB 108 requires an entity to evaluate the impact of correcting all misstatements, including both the carryover and reversing effects of prior year misstatements, on current year financial statements. If a misstatement is material to the current year financial statements, the prior year financial statements should also be corrected, even though such revision was, and continues to be, immaterial to the prior year financial statements. Correcting prior year financial statements for immaterial errors would not require previously filed reports to be amended. Such correction should be made in the current period filings. The adoption of SAB 108 as of December 31, 2006 did not have a material effect on our financial position and results of operation. | ||
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities, which permits entities to choose to measure many financial assets and financial liabilities at fair value. Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. We are currently evaluating the impact, if any, the adoption of SFAS No. 159 will have on our financial statements. |
23
12. | SIGNIFICANT CUSTOMER RELATIONSHIP | |
At December 31, 2006, 2005 and 2004, we had one customer relationship that provided 10.3%, 11.9% and 10.3% of our total revenue. For this customer, we provide fitness center management and employee wellness administration services for approximately 50 locations. The agreement with this customer was recently renewed and expires December 31, 2009, and will automatically renew for successive one year periods unless either party delivers written notice at least 90 days prior to termination. We believe that our relationship with this customer is good. | ||
13. | RELATED PARTY TRANSACTION | |
K. James Ehlen, M.D., a member of our Board of Directors, provides to us certain medical advisory services, in addition to supporting the development of our strategy for corporate health management services. For 2006, 2005, and 2004, Dr. Ehlen was paid $4,500, $66,336, and $100,000 for his services. | ||
14. | BUSINESS SEGMENTS | |
Effective with the fourth quarter of 2006, we organized our business into two operating segments: Fitness Management Services and Health Management Services. Within each of these business segments, we provide two types of service: (i) Staffing Services, and (ii) Program and Consulting Services. We assess and manage the performance of each business segment by reviewing internally-generated reports that detail revenue and gross profit results for each of our customer sites. This information is used to formulate plans regarding the future prospects of our business, and aids in our determination of how we will invest our resources to ensure we achieve our future revenue and profitability growth targets. |
24
2006 | 2005 | 2004 | ||||||||||
Revenue |
||||||||||||
Fitness Management Services |
||||||||||||
Staffing Services |
$ | 39,670,546 | $ | 38,226,444 | $ | 38,446,085 | ||||||
Program and Consulting Services |
2,574,463 | 2,392,272 | 1,678,343 | |||||||||
42,245,009 | 40,618,716 | 40,124,428 | ||||||||||
Health Management Services |
||||||||||||
Staffing Services |
13,669,201 | 12,267,973 | 11,478,361 | |||||||||
Program and Consulting Services |
7,664,330 | 2,055,516 | 851,879 | |||||||||
21,333,531 | 14,323,489 | 12,330,240 | ||||||||||
Total Revenue |
||||||||||||
Staffing Services |
53,339,747 | 50,494,417 | 49,924,446 | |||||||||
Program and Consulting Services |
10,238,793 | 4,447,788 | 2,530,222 | |||||||||
$ | 63,578,540 | $ | 54,942,205 | $ | 52,454,668 | |||||||
Gross Profit |
||||||||||||
Fitness Management Services |
||||||||||||
Staffing Services |
$ | 8,861,829 | $ | 8,772,194 | $ | 8,964,117 | ||||||
Program and Consulting Services |
1,129,585 | 810,401 | 735,487 | |||||||||
9,991,414 | 9,582,595 | 9,699,604 | ||||||||||
Health Management Services |
||||||||||||
Staffing Services |
3,399,875 | 3,499,117 | 3,407,956 | |||||||||
Program and Consulting Services |
4,239,295 | 735,462 | 351,657 | |||||||||
7,639,170 | 4,234,579 | 3,759,613 | ||||||||||
Total Gross Profit |
||||||||||||
Staffing Services |
12,261,704 | 12,271,311 | 12,372,073 | |||||||||
Program and Consulting Services |
5,368,880 | 1,545,863 | 1,087,144 | |||||||||
$ | 17,630,584 | $ | 13,817,174 | $ | 13,459,217 | |||||||
25
15. | QUARTERLY FINANCIAL INFORMATION (UNAUDITED) |
Quarter ended | |||||||||||||||||||
March 31, | June 30, | September 30, | December 31, | ||||||||||||||||
(Restated) | |||||||||||||||||||
2006 |
|||||||||||||||||||
Revenue |
$ | 14,567,261 | $ | 15,575,130 | $ | 16,340,380 | $ | 17,095,769 | |||||||||||
Gross profit |
3,604,480 | 4,160,014 | 5,278,628 | 4,587,462 | |||||||||||||||
Net earnings
(loss) applicable to common
shareholders |
(1,013,191 | ) | 727,474 | 1,173,841 | 463,549 | ||||||||||||||
Net earnings
(loss) per common share |
|||||||||||||||||||
Basic |
$ | (0.07 | ) | $ | 0.04 | $ | 0.06 | $ | 0.02 | ||||||||||
Diluted |
(0.07 | ) | 0.02 | 0.06 | 0.02 | ||||||||||||||
Weighted average common shares outstanding |
|||||||||||||||||||
Basic |
15,001,832 | 18,831,169 | 18,963,948 | 19,085,789 | |||||||||||||||
Diluted |
15,001,832 | 20,310,830 | 19,550,662 | 19,823,346 |
Quarter ended | |||||||||||||||||||
March 31, | June 30, | September 30, | December 31, | ||||||||||||||||
2005 |
|||||||||||||||||||
Revenue |
$ | 13,465,101 | $ | 13,678,615 | $ | 13,464,278 | $ | 14,334,211 | |||||||||||
Gross profit |
3,441,802 | 3,450,616 | 3,498,814 | 3,425,942 | |||||||||||||||
Net earnings (loss) applicable to common
shareholders |
627,934 | 498,183 | 506,488 | (428,204 | ) | ||||||||||||||
Net earnings (loss) per common share |
|||||||||||||||||||
Basic |
$ | 0.05 | $ | 0.04 | $ | 0.04 | $ | (0.03 | ) | ||||||||||
Diluted |
0.04 | 0.03 | 0.03 | (0.03 | ) | ||||||||||||||
Weighted average common shares outstanding |
|||||||||||||||||||
Basic |
12,619,603 | 12,652,370 | 12,836,971 | 13,008,291 | |||||||||||||||
Diluted |
16,614,522 | 16,618,997 | 16,662,753 | 13,008,291 |
26
16. | RESTATEMENT | |
On November 12, 2007, subsequent to our third quarter earnings release on November 5, 2007, we determined that a $1,576,454 deemed dividend to preferred shareholders should have been reflected in our financial statements for the quarter ended March 31, 2006. The effect of this restatement results in a reduction to net earnings applicable to common shareholders in our consolidated statement of operations for the quarter ended March 31, 2006, with a corresponding increase to additional paid in capital in our consolidated balance sheet as of March 31, 2006. In Amendment No. 1 to our Original Filing, we restated our consolidated balance sheet for the quarter ended March 31, 2006 and for the year ended December 31, 2006, our consolidated statements of operations and cash flows for the quarter ended March 31, 2006 and year ended December 31, 2006, and the notes related thereto. No other quarterly reporting periods during our year ended December 31, 2006 were affected by this restatement. This restatement will result in no change to total net earnings or to total stockholders equity as of December 31, 2006 and March 31, 2006. | ||
The $1,576,454 deemed dividend to preferred shareholders was determined in accordance with Emerging Issues Task Force (EITF) Number 98-5, Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratio. This deemed dividend is a one-time, non-cash adjustment related to the automatic conversion of our Series B Preferred Stock to common stock on March 10, 2006. | ||
The Audit Committee worked closely with our management to review the restatement and our policies and practices related to the restatement. The Audit Committee has determined that, despite this restatement, our internal controls over accounting and financial reporting are effective, and that the restatement does not relate to any misconduct on the part of management. | ||
Following is a presentation of the effects of this restatement on our consolidated financial statements for the periods that were affected by this restatement. All other numbers reported for these periods not affected by this restatement are the same as originally reported. | ||
The following table presents the effect of the restatement on our consolidated balance sheet for the quarter ended March 31, 2006: |
As Reported | Restatement | As Restated | ||||||||||
STOCKHOLDERS EQUITY |
||||||||||||
Common stock, $0.01 par value |
$ | 189,304 | | $ | 189,304 | |||||||
Additional paid-in capital |
24,266,420 | 1,576,454 | 25,842,874 | |||||||||
Accumulated comprehensive income |
(898 | ) | | (898 | ) | |||||||
Accumulated deficit |
(4,713,558 | ) | (1,576,454 | ) | (6,290,012 | ) | ||||||
$ | 19,741,268 | | $ | 19,741,268 | ||||||||
27
As Reported | Restatement | As Restated | ||||||||||
NET EARNINGS |
$ | 659,673 | | $ | 659,673 | |||||||
Deemed dividend to preferred shareholders |
| 1,576,454 | 1,576,454 | |||||||||
Dividend to preferred shareholders |
96,410 | | 96,410 | |||||||||
NET EARNINGS
(LOSS) APPLICABLE TO COMMON SHAREHOLDERS |
$ | 563,263 | $ | (1,576,454 | ) | $ | (1,013,191 | ) | ||||
NET EARNINGS
(LOSS) PER COMMON SHARE: |
||||||||||||
Basic |
$ | 0.04 | $ | (0.07 | ) | |||||||
Diluted |
0.01 | (0.07 | ) | |||||||||
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING |
||||||||||||
Basic |
15,001,832 | 15,001,832 | ||||||||||
Diluted |
19,666,941 | 15,001,832 |
As Reported | Restatement | As Restated | ||||||||||
Noncash investing and financing activities affecting cash flows: |
||||||||||||
Deemed to preferred shareholders |
| $ | (1,576,454 | ) | $ | (1,576,454 | ) |
As Reported | Restatement | As Restated | ||||||||||
STOCKHOLDERS EQUITY |
||||||||||||
Common stock, $0.01 par value |
$ | 192,202 | | $ | 192,202 | |||||||
Additional paid-in capital |
25,989,447 | 1,576,454 | 27,565,901 | |||||||||
Accumulated comprehensive income |
(35,186 | ) | | (35,186 | ) | |||||||
Accumulated deficit |
(2,348,695 | ) | (1,576,454 | ) | (3,925,149 | ) | ||||||
$ | 23,797,768 | | $ | 23,797,768 | ||||||||
As Reported | Restatement | As Restated | ||||||||||
NET EARNINGS |
$ | 3,024,537 | | $ | 3,024,537 | |||||||
Deemed dividend to preferred shareholders |
| 1,576,454 | 1,576,454 | |||||||||
Dividend to preferred shareholders |
96,410 | | 96,410 | |||||||||
NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS |
$ | 2,928,127 | $ | (1,576,454 | ) | $ | 1,351,673 | |||||
NET EARNINGS PER COMMON SHARE: |
||||||||||||
Basic |
$ | 0.16 | $ | 0.07 | ||||||||
Diluted |
0.11 | 0.03 | ||||||||||
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING |
||||||||||||
Basic |
18,023,298 | 18,023,298 | ||||||||||
Diluted |
19,736,785 | 18,772,675 |
28
As Reported | Restatement | As Restated | ||||||||||
Noncash investing and financing activities affecting cash flows: |
||||||||||||
Deemed to preferred shareholders |
| $ | (1,576,454 | ) | $ | (1,576,454 | ) |
29
Balance at | Charged to | Charged to | Balance | |||||||||||||||
Beginning | Costs and | Other accounts | Deductions | at End | ||||||||||||||
Description | of Period | Expenses | Describe | Describe | of Period | |||||||||||||
Trade and other accounts
receivable allowances: |
||||||||||||||||||
Year ended December 31, 2006
|
$ | 200,700 | $ | 104,000 | | $ | (21,600 | )(a) | $ | 283,100 | ||||||||
Year ended December 31, 2005
|
$ | 210,700 | $ | 12,400 | | $ | (22,400 | )(a) | $ | 200,700 | ||||||||
Year ended December 31, 2004
|
$ | 131,000 | $ | 79,700 | | $ | | (a) | $ | 210,700 |
(a) | Accounts receivable written off as uncollectible |
30
(a) | Documents filed as part of this report. |
(1) | Financial Statements. The following financial statements are included in Part II, Item 8 of this Annual Report on Form 10-K/A: | ||
Report of Grant Thornton LLP on Consolidated Financial Statements and Financial Statement Schedule as of December 31, 2006 and 2005 and for each of the three years in the period ended December 31, 2006 | |||
Consolidated Balance Sheets as of December 31, 2006 and 2005 | |||
Consolidated Statements of Operations for each of the three years in the period ended December 31, 2006 | |||
Consolidated Statements of Stockholders Equity for each of the three years in the period ended December 31, 2006 | |||
Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 2006 | |||
Notes to Consolidated Financial Statements | |||
(2) | Financial Statement Schedules. The following consolidated financial statement schedule is included in Item 8: | ||
Schedule II-Valuation and Qualifying Accounts | |||
All other financial statement schedules have been omitted, because they are not applicable, are not required, or the information is included in the Financial Statements or Notes thereto | |||
(3) | Exhibits. See Exhibit Index to Form 10-K/A immediately following the signature page of this Form 10-K/A |
31
By
|
/s/ Gregg O. Lehman, Ph.D.
|
By | /s/ Wesley W. Winnekins
|
|||||||
Gregg O. Lehman, Ph.D. | Wesley W. Winnekins | |||||||||
Chief Executive Officer | Chief Financial Officer |
Signatures | Title | |||
/s/ Gregg O. Lehman, Ph.D.
|
Chief Executive Officer, President (principal executive officer) and Director | November 20, 2007 | ||
/s/ Wesley W. Winnekins
|
Chief Financial Officer (principal financial and accounting officer) | November 20, 2007 | ||
/s/ Mark W. Sheffert*
|
Chairman | November 20, 2007 | ||
/s/ Jerry V. Noyce*
|
Vice Chairman and Director | November 20, 2007 | ||
/s/ K. James Ehlen, M.D.*
|
Director | November 20, 2007 |
32
Signatures | Title | |||||
/s/ Robert J. Marzec*
|
Director | November 20, 2007 | ||||
/s/ John C. Penn*
|
Director | November 20, 2007 | ||||
/s/
Linda Hall Whitman, Ph.D.*
|
Director | November 20, 2007 | ||||
/s/ Rodney A. Young*
|
Director | November 20, 2007 | ||||
Director | ||||||
Director | ||||||
*By: |
/s/
Wesley W. Winnekins
As Attorney-in-Fact pursuant to Powers of Attorney previously filed. Date: November 20, 2007 |
33
Exhibit No. | Description | |
3.1
|
Articles of Incorporation, as amended on September 20, 2004 incorporated by reference to Exhibit 3.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2004 | |
3.2
|
Certificate of Designation, Preferences and Rights of Series A Convertible Preferred Stock incorporated by reference to Exhibit 3.2 to our Registration Statement on Form S-1 (No. 333-131045) filed January 13, 2006 | |
3.3
|
Certificate of Designation, Preferences and Rights of Series B Convertible Preferred Stock incorporated by reference to Exhibit 4.1 to our Form 8-K filed November 16, 2005 | |
3.4
|
Restated By-Laws of the Company incorporated by reference to the Companys Registration Statement on Form SB-2, File No. 33-83784C | |
4.1
|
Specimen of Common Stock Certificate incorporated by reference to the Companys Registration Statement on Form SB-2, File No. 33-83784C | |
10.1
|
Standard Office Lease Agreement (Net) dated as of June 13, 1996 covering a portion of the Companys headquarters incorporated by reference to Exhibit 10.8 to our Annual Report on Form 10-KSB for the year ended December 31, 1996, File No. 000-25064 | |
10.2
|
Amendment dated March 1, 2001 to Standard Office Lease Agreement (Net) dated as of June 13, 1996 covering a portion of the Companys headquarters-incorporated by reference to Exhibit 10.12 to our Form 10-K for the year ended December 31, 2000, File No. 000-25064 | |
10.3
|
Second Amendment, dated June 12, 2002, to Standard Office Lease Agreement dated as of June 13, 1996- incorporated by reference to Exhibit 10.13 to our Form 10-Q for the quarter ended June 30, 2002 | |
10.4
|
Companys 2005 Stock Option Plan incorporated by reference to Exhibit 10.1 to our report on Form 8-K filed June 14, 2005 (1) | |
10.5
|
Forms of Incentive Stock Option Agreement (1) | |
10.6
|
Form of Non-Qualified Stock Option Agreement under the 2005 Stock Option Plan incorporated by reference to Exhibit 10.2 to our report on Form 8-K dated June 14, 2005 (1) | |
10.7
|
Employment Agreement dated November 30, 2000 between the Company and Jerry V. Noyce incorporated by reference to Exhibit 10.9 to our Form 10-K for the fiscal year ended December 31, 2000, File No. 000-25064 (1) | |
10.8
|
Amendment, dated December 1, 2006, to Employment Agreement dated November 30, 2000 between the Company and Jerry V. Noyce incorporated by reference to Exhibit 99.1 to our report on Form 8-K filed December 4, 2006 (1) | |
10.9
|
Employment Agreement dated February 9, 2001 between the Company and Wesley W. Winnekins incorporated by reference to Exhibit 10.11 to our Form 10-K for the fiscal year ended December 31, 2000, File No. 000-25064 (1) | |
10.10
|
Amendment, dated as of December 21, 2006, to Employment Agreement dated February 9, 2001 between the Company and Wesley W. Winnekins (1) incorporated by reference to Exhibit 10.10 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.11
|
Employment Agreement dated March 1, 2003 between the Company and Jeanne Crawford incorporated by reference to Exhibit 10.9 to our Form 10-K for the fiscal year ended December 31, 2002 (1) |
34
Exhibit No. | Description | |
10.12
|
Amendment, dated as of December 21, 2006, to Employment Agreement dated March 1, 2003 between the Company and Jeanne Crawford (1) incorporated by reference to Exhibit 10.12 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.13
|
Amended and Restated Employment Agreement dated March 25, 2003 between the Company and James A. Narum incorporated by reference to Exhibit 10.7 to our Annual Report on Form 10-K for the year ended December 31, 2002 (1) | |
10.14
|
Employment Agreement dated December 8, 2003 between the Company and Brian Gagne incorporated by reference to Exhibit 10.10 to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2005 (1) | |
10.15
|
Amendment, dated as of December 21, 2006, to Employment Agreement dated December 8, 2003 between the Company and Brian Gagne (1) incorporated by reference to Exhibit 10.15 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.16
|
Employment Agreement dated December 22, 2003 between the Company and Michael Seethaler incorporated by reference to Exhibit 10.11 to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2005 (1) | |
10.17
|
Amendment, dated as of December 21, 2006, to Employment Agreement dated December 22, 2003 between the Company and Michael Seethaler (1) incorporated by reference to Exhibit 10.17 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.18
|
Employment Agreement dated August 13, 2001 between the Company and Dave Hurt incorporated by reference to Exhibit 10.12 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2005 (1) | |
10.19
|
Employment Agreement dated December 8, 2003 between the Company and Katherine Hamlin incorporated by reference to Exhibit 10.13 to our Form 10-K for the fiscal year ended December 31, 2005 (1) | |
10.20
|
Amendment, dated as of December 21, 2006, to Employment Agreement dated December 8, 2003 between the Company and Katherine Hamlin (1) incorporated by reference to Exhibit 10.20 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.21
|
Employment Agreement dated December 23, 2005 between the Company and John F. Ellis incorporated by reference to Exhibit 10.16 Form 10-K for the fiscal year ended December 31, 2005 (1) | |
10.22
|
Amendment, dated as of December 21, 2006, to Employment Agreement dated December 23, 2005 between the Company and John F. Ellis (1) incorporated by reference to Exhibit 10.22 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.23
|
Employment Agreement dated December 23, 2005 between the Company and Peter A. Egan incorporated by reference to Exhibit 10.17 Form 10-K for the fiscal year ended December 31, 2005 (1) | |
10.24
|
Amendment, dated as of December 21, 2006, to Employment Agreement dated December 23, 2005 between the Company and Peter A. Egan (1) incorporated by reference to Exhibit 10.24 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.25
|
Employment Agreement dated December 1, 2006 between the Company and Gregg O. Lehman, Ph.D. incorporated by reference to Exhibit 99.2 to our report on Form 8-K for the fiscal year ended December 4, 2006 (1) | |
10.26
|
Restricted Stock Agreement, dated as of January 1, 2007, between the Company and Gregg O. Lehman, Ph.D. (1) incorporated by reference to Exhibit 10.15 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.27
|
Credit Agreement, dated August 22, 2003, between the Company and Wells Fargo Bank, National Association incorporated by reference to Exhibit 10.11 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003 |
35
Exhibit No. | Description | |
10.28
|
Third Amendment, dated August 25, 2003, to Standard Office Lease Agreement dated as of June 13, 1996, between the Company and NEOC Holdings LLC incorporated by reference to Exhibit 10.14 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003 | |
10.29
|
Second Amendment dated May 14, 2004 to Credit Agreement and Waiver of Defaults, dated August 22, 2003, between the Company and Wells Fargo Bank, N.A. incorporated by reference to Exhibit 10.16 to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2004 | |
10.30
|
Third Amendment to Credit Agreement and Consent dated December 29, 2004 to Credit Agreement dated August 22, 2003, between the Company and Wells Fargo Bank, N.A. incorporated by reference to Exhibit 10.20 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2004 | |
10.31
|
Securities Purchase Agreement dated November 14, 2005 incorporated by reference to Exhibit 10.1 to our report on Form 8-K filed November 16, 2005 | |
10.32
|
Registration Rights Agreement dated November 14, 2005 incorporated by reference to Exhibit 10.2 to our report on Form 8-K filed November 16, 2005 | |
10.33
|
Form of Warrant issued pursuant to the Securities Purchase Agreement dated November 14, 2005 incorporated by reference to Exhibit 10.3 to our report on Form 8-K filed November 16, 2005 | |
10.34
|
Stock Purchase Agreement dated December 23, 2005 between the Company, HealthCalc.Net, Inc., Peter A. Egan and John F. Ellis, among others incorporated by reference to Exhibit 10.1 to our report on Form 8-K filed on December 29, 2005 | |
10.35
|
Escrow Agreement dated December 23, 2005 between the Company, Wells Fargo Bank, National Association, Peter A. Egan and John F. Ellis, among others incorporated by reference to Exhibit 10.2 to our report on Form 8-K filed December 29, 2005 | |
10.36
|
Shareholders Agreement dated December 23, 2005 between the Company, Peter A. Egan and John F. Ellis incorporated by reference to Exhibit 10.3 to our report on Form 8-K filed December 29, 2005 | |
10.37
|
Fourth Amendment dated June 6, 2006 to Credit Agreement, dated August 22, 2003, between the Company and Wells Fargo Bank, N.A. incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 | |
10.38
|
Form of Amendment No. 1 to Warrants issued November 14, 2005 incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 | |
10.39
|
Form of Amendment No. 1 to Registration Rights Agreement incorporated by reference to Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 | |
10.40
|
Director Compensation Arrangements (1) incorporated by reference to Exhibit 10.40 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.41
|
2007 Executive Bonus Plan (1) incorporated by reference to Exhibit 10.41 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.42
|
Compensation Arrangements for Executive Officers for Fiscal Year 2007 (1) incorporated by reference to Exhibit 10.42 to our Annual Report on Form 10-K filed March 30, 2007 | |
10.43
|
Cash Incentive Plan (1) incorporated by reference to Exhibit 10.43 to our Annual Report on Form 10-K filed March 30, 2007 | |
11.0
|
Statement re: Computation of Earnings per Share incorporated by reference to Exhibit 11.0 to our Annual Report on Form 10-K/A filed November 19, 2007 |
|
21.1
|
Subsidiaries - incorporated by reference to Exhibit 21.1 to our Annual Report on Form 10-K for the year ended December 31, 2004 |
36
Exhibit No. | Description | |
*23.1
|
Consent of Independent Registered Public Accounting Firm | |
*31.1
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
*31.2
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
*32.1
|
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
*32.2
|
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
* | Filed herewith | |
(1) | Indicates management contract or compensatory plan or arrangement |
37